| ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
| CBFB |
Q13951
|
core-binding factor subunit beta
|
|
0.96 |
0.601 |
0.538 |
| CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
| CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
| CEBPA |
P49715
|
CCAAT enhancer binding protein alpha
|
Transcription factor
|
0.55 |
0.496 |
0.692 |
| CSF1R |
P07333
|
colony stimulating factor 1 receptor
|
Kinase
|
0.13 |
0.448 |
0.808 |
| CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
| DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
| FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
| FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
| FUT4 |
P22083
|
fucosyltransferase 4
|
Enzyme
|
7.7E-06 |
0.505 |
0.731 |
| GATA2 |
P23769
|
GATA binding protein 2
|
|
0.98 |
0.496 |
0.654 |
| HOXA9 |
P31269
|
homeobox A9
|
|
4.4E-05 |
0.521 |
0.692 |
| HOXC5 |
Q00444
|
homeobox C5
|
Transcription factor
|
5.8E-05 |
0.682 |
0.269 |
| HSPB1 |
P04792
|
heat shock protein family B (small) member 1
|
|
2.8E-07 |
0.436 |
0.808 |
| KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
| KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
| MIR223 |
|
microRNA 223
|
|
|
0.433 |
0.808 |
| MLLT10 |
P55197
|
MLLT10 histone lysine methyltransferase DOT1L cofactor
|
Transcription factor
|
1.00 |
0.551 |
0.462 |
| MPO |
P05164
|
myeloperoxidase
|
Enzyme
|
7.1E-15 |
0.377 |
0.923 |
| MYH11 |
P35749
|
myosin heavy chain 11
|
|
0.77 |
0.528 |
0.731 |
| NPM1 |
P06748
|
nucleophosmin 1
|
Chaperone
|
1.00 |
0.464 |
0.846 |
| NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
| NSD1 |
Q96L73
|
nuclear receptor binding SET domain protein 1
|
Epigenetic regulator
|
1.00 |
0.505 |
0.769 |